Literature DB >> 2556451

Placental corticotropin-releasing hormone may be a stimulator of maternal pituitary adrenocorticotropic hormone secretion in humans.

A Sasaki1, O Shinkawa, K Yoshinaga.   

Abstract

To clarify the physiological role of placental corticotropin-releasing hormone (CRH), we measured plasma CRH, ACTH, and cortisol throughout pregnancy. Cerebrospinal fluid (CSF) CRH levels and ACTH responsiveness to synthetic CRH were also quantified in pregnant and nonpregnant women. Maternal plasma CRH levels, which increased progressively during pregnancy, correlated well with both ACTH and cortisol in early labor, delivery, and postpartum samples, and also with cortisol levels in samples before labor. CSF CRH levels in term pregnant women did not differ from those of nonpregnant women. CRH infusion that attained similar plasma CRH levels to those found in late pregnancy elicited significant ACTH release in vivo and regular CRH test provoked normal ACTH response during early pregnancy but no response during late pregnancy. We concluded that: (a) maternal pituitary-adrenal axis correlates well with plasma CRH levels, which are high enough to provoke ACTH release from maternal pituitary; (b) hypothalamic CRH secretion in term pregnant women is not exaggerated; and (c) maternal pituitary is responsive to synthetic CRH in early but not late pregnancy, suggesting that maternal pituitary-adrenal axis is already activated by high circulating CRH. Placental CRH may be an important stimulator of the maternal pituitary-adrenal axis during pregnancy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2556451      PMCID: PMC304083          DOI: 10.1172/JCI114390

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  28 in total

1.  Continuous administration of synthetic ovine corticotropin-releasing factor in man. Physiological and pathophysiological implications.

Authors:  H M Schulte; G P Chrousos; P W Gold; J D Booth; E H Oldfield; G B Cutler; D L Loriaux
Journal:  J Clin Invest       Date:  1985-06       Impact factor: 14.808

2.  Corticotropin-releasing factor. Proceedings of a conference, February 20-24, 1984 sponsored by the Kroc Foundation.

Authors: 
Journal:  Fed Proc       Date:  1985-01

3.  High levels of corticotropin-releasing hormone immunoactivity in maternal and fetal plasma during pregnancy.

Authors:  R S Goland; S L Wardlaw; R I Stark; L S Brown; A G Frantz
Journal:  J Clin Endocrinol Metab       Date:  1986-11       Impact factor: 5.958

4.  The responses of plasma adrenocorticotropin and cortisol to corticotropin-releasing hormone (CRH) and cerebrospinal fluid immunoreactive CRH in anorexia nervosa patients.

Authors:  M Hotta; T Shibasaki; A Masuda; T Imaki; H Demura; N Ling; K Shizume
Journal:  J Clin Endocrinol Metab       Date:  1986-02       Impact factor: 5.958

5.  Increased plasma concentration of N-terminal beta-lipotrophin and unbound cortisol during pregnancy.

Authors:  A B Abou-Samra; M Pugeat; H Dechaud; L Nachury; B Bouchareb; M Fevre-Montange; J Tourniaire
Journal:  Clin Endocrinol (Oxf)       Date:  1984-02       Impact factor: 3.478

6.  Human corticotropin-releasing factor in man: pharmacokinetic properties and dose-response of plasma adrenocorticotropin and cortisol secretion.

Authors:  T H Schürmeyer; P C Avgerinos; P W Gold; W T Gallucci; T P Tomai; G B Cutler; D L Loriaux; G P Chrousos
Journal:  J Clin Endocrinol Metab       Date:  1984-12       Impact factor: 5.958

7.  Presence of immunoreactive corticotropin-releasing factor in human cerebrospinal fluid.

Authors:  T Suda; F Tozawa; T Mouri; H Demura; K Shizume
Journal:  J Clin Endocrinol Metab       Date:  1983-07       Impact factor: 5.958

8.  Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients.

Authors:  C B Nemeroff; E Widerlöv; G Bissette; H Walléus; I Karlsson; K Eklund; C D Kilts; P T Loosen; W Vale
Journal:  Science       Date:  1984-12-14       Impact factor: 47.728

9.  Immunoreactive corticotropin-releasing factor is present in human maternal plasma during the third trimester of pregnancy.

Authors:  A Sasaki; A S Liotta; M M Luckey; A N Margioris; T Suda; D T Krieger
Journal:  J Clin Endocrinol Metab       Date:  1984-10       Impact factor: 5.958

10.  Serum CBG, free and total cortisol and circadian patterns of adrenal function in normal pregnancy.

Authors:  E Demey-Ponsart; J M Foidart; J Sulon; J C Sodoyez
Journal:  J Steroid Biochem       Date:  1982-02       Impact factor: 4.292

View more
  14 in total

Review 1.  Stress and preterm birth: neuroendocrine, immune/inflammatory, and vascular mechanisms.

Authors:  P D Wadhwa; J F Culhane; V Rauh; S S Barve
Journal:  Matern Child Health J       Date:  2001-06

Review 2.  Placental stress factors and maternal-fetal adaptive response: the corticotropin-releasing factor family.

Authors:  Pasquale Florio; Filiberto M Severi; Pasquapina Ciarmela; Giovina Fiore; Giulia Calonaci; Angelica Merola; Claudio De Felice; Marco Palumbo; Felice Petraglia
Journal:  Endocrine       Date:  2002-10       Impact factor: 3.633

Review 3.  New aspects of placental endocrinology.

Authors:  F Petraglia; L Calzà; G C Garuti; L Giardino; B M De Ramundo; S Angioni
Journal:  J Endocrinol Invest       Date:  1990-04       Impact factor: 4.256

Review 4.  Anatomical and physiological alterations of pregnancy.

Authors:  Jamil M Kazma; John van den Anker; Karel Allegaert; André Dallmann; Homa K Ahmadzia
Journal:  J Pharmacokinet Pharmacodyn       Date:  2020-02-06       Impact factor: 2.745

Review 5.  The contribution of maternal stress to preterm birth: issues and considerations.

Authors:  Pathik D Wadhwa; Sonja Entringer; Claudia Buss; Michael C Lu
Journal:  Clin Perinatol       Date:  2011-09       Impact factor: 3.430

6.  Endometrial gene expression in early pregnancy: lessons from human ectopic pregnancy.

Authors:  Ricardo F Savaris; Amy E Hamilton; Bruce A Lessey; Linda C Giudice
Journal:  Reprod Sci       Date:  2008-06-30       Impact factor: 3.060

7.  Attenuation of maternal psychophysiological stress responses and the maternal cortisol awakening response over the course of human pregnancy.

Authors:  Sonja Entringer; Claudia Buss; Elizabeth A Shirtcliff; Alison L Cammack; Ilona S Yim; Aleksandra Chicz-DeMet; Curt A Sandman; Pathik D Wadhwa
Journal:  Stress       Date:  2010-05       Impact factor: 3.493

8.  High pregnancy anxiety during mid-gestation is associated with decreased gray matter density in 6-9-year-old children.

Authors:  Claudia Buss; Elysia Poggi Davis; L Tugan Muftuler; Kevin Head; Curt A Sandman
Journal:  Psychoneuroendocrinology       Date:  2010-01       Impact factor: 4.905

Review 9.  Vital and vulnerable functions of the primate placenta critical for infant health and brain development.

Authors:  Christopher L Coe; Gabriele R Lubach
Journal:  Front Neuroendocrinol       Date:  2014-04-01       Impact factor: 8.606

10.  Maternal Glucocorticoid Metabolism Across Pregnancy: A Potential Mechanism Underlying Fetal Glucocorticoid Exposure.

Authors:  David Q Stoye; Ruth Andrew; William A Grobman; Emma K Adam; Pathik D Wadhwa; Claudia Buss; Sonja Entringer; Gregory E Miller; James P Boardman; Jonathan R Seckl; Lauren S Keenan-Devlin; Ann E B Borders; Rebecca M Reynolds
Journal:  J Clin Endocrinol Metab       Date:  2020-03-01       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.